Vanessa Azzolina, Franziska Schauer, Julia Felicitas Pilz, Alexander Zink, Kilian Eyerich, Anna Caroline Pilz
{"title":"Scabies Management Outcomes: Identification of Risk Factors for Treatment Success or Failure.","authors":"Vanessa Azzolina, Franziska Schauer, Julia Felicitas Pilz, Alexander Zink, Kilian Eyerich, Anna Caroline Pilz","doi":"10.5826/dpc.1502a5077","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Scabies is a parasitic infectious skin disease classified as a neglected tropical disease by the World Health Organization in 2017. Currently, it is becoming a major challenge in high-income countries, with rapidly rising incidence and increasing reports about treatment failure.</p><p><strong>Objectives: </strong>Factors that are associated with treatment failure or success were evaluated.</p><p><strong>Methods: </strong>This non-interventional prospective observational study was conducted as a questionnaire survey at the Department of Dermatology and Venereology of the University of Freiburg from January to November 2023. Patients that still suffered from scabies 2-6 weeks after medical treatment were classified as \"failure\"; those who were free of scabies belonged to the success group.</p><p><strong>Results: </strong>Of 102 participants, with a mean age of 34.4 ± 17.3 years (male: 60.4%), 77 (75.5%) were assigned to the success and 25 (24.5%) to the failure group. A larger proportion of the latter was clinically more severely affected, applied permethrin monotherapy, did not undertake special decontamination measures, but used alcohol as a disinfectant. Treatment success was associated with an additional systemic treatment, a repeated intake of ivermectin, and intensified decontamination measures such as storage of clothes in plastic bags for four days or vacuum cleaning of car seats.</p><p><strong>Conclusions: </strong>Our findings indicate that a consistent second-dose administration of ivermectin and refraining from permethrin monotherapy may be advisable.</p>","PeriodicalId":11168,"journal":{"name":"Dermatology practical & conceptual","volume":"15 2","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12090963/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dermatology practical & conceptual","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5826/dpc.1502a5077","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Scabies is a parasitic infectious skin disease classified as a neglected tropical disease by the World Health Organization in 2017. Currently, it is becoming a major challenge in high-income countries, with rapidly rising incidence and increasing reports about treatment failure.
Objectives: Factors that are associated with treatment failure or success were evaluated.
Methods: This non-interventional prospective observational study was conducted as a questionnaire survey at the Department of Dermatology and Venereology of the University of Freiburg from January to November 2023. Patients that still suffered from scabies 2-6 weeks after medical treatment were classified as "failure"; those who were free of scabies belonged to the success group.
Results: Of 102 participants, with a mean age of 34.4 ± 17.3 years (male: 60.4%), 77 (75.5%) were assigned to the success and 25 (24.5%) to the failure group. A larger proportion of the latter was clinically more severely affected, applied permethrin monotherapy, did not undertake special decontamination measures, but used alcohol as a disinfectant. Treatment success was associated with an additional systemic treatment, a repeated intake of ivermectin, and intensified decontamination measures such as storage of clothes in plastic bags for four days or vacuum cleaning of car seats.
Conclusions: Our findings indicate that a consistent second-dose administration of ivermectin and refraining from permethrin monotherapy may be advisable.